Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir for Treatment-Naive and Treatment-Experienced Non-Cirrhotic Patients With Hepatitis C Virus Genotype 1b Receiving Hemodialysis
Phase of Trial: Phase IV
Latest Information Update: 27 Aug 2017
At a glance
- Drugs Dasabuvir (Primary) ; Ombitasvir/paritaprevir/ritonavir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms PIVOTAL
- 17 Mar 2017 Planned End Date changed from 1 Dec 2017 to 13 May 2018.
- 17 Mar 2017 Planned primary completion date changed from 1 Oct 2017 to 13 Mar 2018.
- 17 Mar 2017 Status changed from not yet recruiting to recruiting.